Helicobacter pylori infection in Finland

Annals of Medicine

Volumn 36, Issue 2, 2004, Pages 82-88

  Rautelin, Hilpi ^a   Kosunen, Timo U ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Gastric cancer; Gastritis; Helicobacter pylori; Peptic ulcer disease

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBODY TITER; ANTIMICROBIAL THERAPY; ATROPHIC GASTRITIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CANCER CLASSIFICATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA FINGERPRINTING; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RATE; INFECTION RISK; LYMPHOCYTIC INFILTRATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; RECURRENT PEPTIC ULCER; REVIEW; RISK FACTOR; SEROPREVALENCE; STOMACH BIOPSY; STOMACH CARCINOMA; STOMACH LYMPHOMA; UREA BREATH TEST;

FINLAND; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA; PEPTIC ULCER; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 1942473107     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310020293     Document Type: Review

References (64)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983(1)1273-5.
2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Human 1994;61:177-240.
4. Tomb JF, White O, Kerlavage A, Clayton R, Sutton G, Fleischmann R, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
5. Alm R, Ling LS, Moir D, King B, Brown E, Doig P, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999;97:176-80.
6. Marshall B, Armstrong J, McGechie D, Glancy R. Attempt to fulfill Koch's postulates for pyloric campylobacter. Med J Aust 1985;142:436-9.
7. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. Scand J Gastroenterol 1991;26:1057-65.
8. Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997;314:1430-1.
9. Malfertheiner P, Mégraud F, O'Morain C, Hungin S, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002;16:167-80.
10. Suomen gastroenterologiayhdistys ry (Niemelä S, Ashorn M, Färkkilä M, Kujala P, Kunnamo I, Pikkarainen P). Helikobakteeri- infektion diagnostiikka ja hoito. Käypä hoito-suositus. Duodecim 2000;116:548-60.
11. Koskenpato J, Färkkilä M, Sipponen P. Helicobacter pylori and different topographic types of gastritis. Scand J Gastroenterol 2002;37:778-84.
12. Oksanen A, Veijola L, Sipponen P, Schauman K-O, Rautelin H. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol 1998;36:955-7.
13. Voutilainen M, Mäntynen T, Kunnamo I, Juhola M, Mecklin JP, Färkkilä M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol 2003;38:109-13.
14. Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen M. the Finnish Gastric Ulcer Study Group. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Gut 1995;36:834-7.
15. Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated ulcer disease. Scand J Gastroenterol 2001;36:817-21.
16. Atherton J. The clinical relevance of strain types of Helicobacter pylori. Gut 1997;40:701-3.
17. Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med 2000;191: 587-92.
18. Rautelin HIK, Oksanen AM, Karttunen RA, Seppälä KY, Virtamo JRK, Aromaa AJ, et al. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class. Ann Med 2000;32:652-6.
19. Karhukorpi J, Yan Y, Kolho K-L, Rautelin H, Lahti M, Sirviö A, et al. cagA, vacA and iceA virulence genes of Helicobacter pylori isolates of children in Finland. Eur J Clin Microbiol Infect Dis 2000;19:790-3.
20. Sande N, Nikulin M, Nilsson I, Wadström T, Laxén F, Härkönen M, et al. Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001;36:928-933.
21. Rautelin H, Sipponen P, Seppälä K, Sarna S, Danielsson D, Kosunen TU. Gastric inflammation and neutrophil-activaring and cytoxin-producing Helicobacter pylori strains. Scand J Gastroenterol 1996;31:639-42.
22. Lee A, Dixon MF, Danon SJ, Kuipers E, Mégraud F, Larsson H, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995;7:461-5.
23. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001;48:743-7.
24. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
25. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-50.
26. Siurala M, Lehtola J, Ihamäki T. Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol 1974;9:441-6.
27. Varis K, Samloff IM, Ihamäki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979;24:187-91.
28. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, et al. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J Clin Microbiol 1998;36:1808-10.
29. 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
30. Kokkola A, Sipponen P, Rautelin H, Härkönen M, Kosunen TU, Haapiainen R, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16:515-20.
31. Varis K, Ihamäki T, Härkönen M, Samloff IM, Siurala M. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anaemia and controls. Scand J Gastroenterol 1979;14:129-39.
32. Clayes D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+, K+ ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340-7.
33. Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000;46:460-3.
34. Kolho K-L, Jusufovic J, Miettinen A, Savilahti E, Rautelin H. Parietal cell antibodies and Helicobacter pylori in children. J Pediatr Gastroenterol Nutr 2000;30:265-8.
35. Stolte M, Bayerdörffer E, Morgner A, Alpen B, Wündisch T, Thiede C, et al. Helicobacter and gastric MALT lymphoma. Gut 2002;50 Suppl III:19-24.
36. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
37. Sipponen P, Marshall BJ. Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am 2000;29:579-92.
38. Sipponen P, Riihelä M, Hyvärinen H, Seppälä K. Chronic nonatrophic ("superficial") gastritis increases the risk of gastric carcinoma. Scand J Gastroenterol 1994;29:336-40.
39. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
40. Howden CW, Leontiadis GI. Extragastric manifestations of Helicobacter pylori - are they relevant? In: Hunt R, Tytgat G, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure. London: Kluwer Academic Publishers; 2000:315-26.
41. Höök-Nikanne J, Varjonen E, Harvima RJ, Kosunen TU. Is Helicobacter pylori infection associated with chronic urticaria. Acta Derm Venereol 2000;80:425-6.
42. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
43. Danesh J, Youngman SH, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999;319:1157-62.
44. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101:252-7.
45. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in general elderly population. BMJ 1997;314:1317-8.
46. Salomaa A, Kosunen TU, Mattila J, Rehnberg-Laiho L, Rautelin H. Age dependent sensitivity and specificity of a helicobacter antibody test in adults, with special reference to atrophic gastritis. Gut 2002;51 Suppl II:A106.
47. Oksanen A, Sipponen P, Sarna S, Rautelin H. Serologic diagnosis of Helicobacter pylori infection in outpatients aged 45 years or less. Eur J Clin Microbiol Infect Dis 2001;20:554-7.
48. Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
49. Lerang F, Haug J, Moum B, Mowinckel P, Berge T, Ragnhildstveit E, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scand J Gastroenterol 1998;33:364-9.
50. Vaira D, Malfertheiner P, Mégraud F, Axon A, Deltenre M, Hirschl A, et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. Lancet 1999;354:30-3.
51. Veijola L, Oksanen A, Löfgren T, Jussila M, Karvonen A, Sipponen P, et al. Preliminary results of two stool antigen tests for detection of Helicobacter pylori in adults. Gut 2002;51 Suppl II:A112.
52. Glupczynski Y, Mégraud F, Lopez-Brea M, Andersen L. European multicentre study of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-3.
53. Rehnberg-Laiho L, Rautelin H, Valle M, Kosunen TU. Persisting Helicobacter antibodies in Finnish children and adolescents between two and twenty years of age. Pediatr Infect Dis J 1998;17:796-9.
54. MacArthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA 1995;273:729-34.
55. Kolho K-L, Korhonen J, Verkasalo M, Lindahl H, Savilahti E, Rautelin H. Helicobacter pylori serology at diagnosis and follow-up of biopsy-verified infection in children. Scand J Infect Dis 2002;34:177-82.
56. Kolho K-L, Karttunen R, Heikkilä P, Lindahl H, Rautelin H. Gastric inflammation is enhanced in children with CagA-positive Helicobacter pylori infection. Pediatr Infect Dis J 1999;18:337-41.
57. Ashorn M, Ruuska T, Mäkipernaa A. Helicobacter pylori and iron deficiency anaemia in children. Scand J Gastroenterol 2001;36:701-5.
58. Kolho K-L, Hölttä P, Alaluusua S, Lindahl H, Savilahti E, Rautelin H. Dental caries is common in Finnish children infected with Helicobacter pylori. Scand J Infect Dis 2001;33:815-7.
59. Bamford KB, Bickley J, Collins JSA, Johnston BT, Potts S, Boston V, et al. Helicobacter pylori:comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993;34:1348-50.
60. Mégraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:73-88.
61. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
62. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et al. Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect 2001;126:37-42.
63. Rehnberg-Laiho L, Salomaa A, Rautelin H, Koskela P, Sarna S, Kosunen TU. Accelerated decline in Helicobacter pylori prevalence rate during the screen and treat project in Vammala, Finland, as demonstrated in 29-45-year-old pregnant women. In: Rehnbetg-Laiho L. Helicobacter pylori in Finland: Seroepidemiological studies. Academic Dissertation, Helsinki Yliopistopaino 2002.
64. Kosunen TU, Höök-Nikanne J, Salomaa A, Sarna S, Aromaa A, Haahtela T. Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy 2002;32:373-8.